-+ 0.00%
-+ 0.00%
-+ 0.00%

PRIME MEDICINE, - PHASE 1/2 TRIAL FOR PM577A EXPECTED TO START IN H2 2026 WITH INITIAL DATA IN 2027

Reuters·07/23/2026 20:05:00

Please log in to view news